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Contamination by the parvovirus Mouse Minute Virus (MMV) remains a challenge in CHO 
biopharmaceutical production processes. As part of developing a risk mitigation strategy against such 
events our group has evaluated the genetic engineering of Chinese Hamster Ovary (CHO) cell lines to 
create a new host cell line that would be resistant to MMV.  While the functional receptor for MMV binding 
to CHO cell surface is unknown, previous work in our group has validated the role of sialic acid on the cell 
surface as important for cell surface binding and internalization of the MMV virus. In this work we further 
characterize the cell surface receptors used by MMV for binding and internalization, as well as the role of 
various cytoskeletal elements and proteins involved in virus transport and entry into the nucleus. 
Sialyltransferases are a group of enzymes that catalyze the transfer of sialic acid to the glycan moiety of 
glyoconjugates. In-vitro binding studies using glycan-arrays have indicated that MMV binds preferentially 
to α-2,3 linked sialylated glycans and do not bind to α-2,6 sialylated glycans. CHO cells have six different 
sialyl transferases (ST3Gal 1-6), that transfer sialic acid in a α-2,3 linkage specific manner. In this work 
we systematically created targeted mutations within genes encoding for the ST3Gal 1,3 4 & 6 
sialyltransferases, and then probed for their role in MMV infectivity by challenging each cell line for their 
ability to resist viral entry. Results indicated that of the sialyltransferases mutations within St3Gal4 had a 
predominant effect on MMV binding and internalization resulting in a 54-88% decrease in infection 
compared to the control WT cells. Based on previous work with mutants that created truncated O-glycans, 
we hypothesized that St3Gal1 knock-outs would have a significant effect on MMV infectivity. We also 
sought to replace the α-2,3 sialylated phenotype with α-2,6 sialylation on the glycoproteins expressed in 
the viral resistant host cell lines by over-expression of the St6Gal1 gene. Such an approach would also 
make the therapeutic protein have more “human” like glycosylation and replace the terminal sialic acid on 
therapeutic molecules. Once MMV is able to enter the cell, it uses various cellular mechanisms for virus 
transport to and into the nucleus. We targeted two genes Vimentin and Caspase-3 involved in vesicular 
transport and virus entry into the nucleus, with the aim of further inhibiting virus replication in CHO host 
cell lines.  
Model recombinant proteins were transfected into the new host cell lines and growth, IgG productivity and 
critical product quality attributes examined. Our data demonstrate that viral resistance against MMV virus 
can be incorporated into CHO production cell lines, adding another level of “defense”, against the 
devastating financial consequences of this virus infection, without compromising recombinant protein 
yield or quality. 
 
